CO2 GRO Inc V.GROW

NEWS, NEWS, Read all about it

[cashmein]

TORONTO, ON / ACCESSWIRE / July 28, 2021 / Toronto based CO2 GRO Inc. ("GROW") (TSXV:GROW, OTCQB:BLONF, Frankfurt: 4021) is pleased to announce a commercial feasibility of a CO2 Delivery Solutions™ system with a US based floriculture greenhouse ("Client"). The Client has requested not to be named, nor the type of flower being grown or location of their greenhouse for competitive reasons.

The commercial feasibility will be conducted on a section of the greenhouse for approximately 12 months. The goals of the feasibility are to accelerate the growth of flowers to blooming in order to bring products to market sooner, as well as pathogen protection. Scientific research and field trials conducted by CO2 GRO as well as a flower commercial feasibility have demonstrated the benefits of CO2 Delivery Solutions™ technology to deliver significant improvements in flower appearance. The client has paid a fee of CAD$25,000 for the commercial feasibility.

GROW's VP Sales & Strategic Alliances, Aaron Archibald stated, "In our early days, floriculture greenhouses showed a lot of interest in our technology. However, the pandemic slowed that market for us as countries initially deemed floriculture as non-essential. We are now seeing more interest again from growers of high value flowers. Our scientific research, field trials and a commercial feasibility highlighted the value our technology provides to growers in an industry where speed to market is crucial. We plan to leverage those results with growers of various high value flowers such as roses, nursery liners and other areas of the floriculture industry where we can provide significant benefits to growers."

[FullCurl]

This is the first time I have heard of them announcing that a company has paid for a feasibility.  I'm wondering if it's almost like an advance payment on what is expected to be a sale. Regardless, it's a good sign. 

[spck11]

Feasability studies were always revenue positive. I think they mentioned it this time because the $25k is a decent number with where their sales numbers are at. Its also a carrot dangle, because if they are paying 25k for a study, imagine what the the outright purchase would be if they were to become a buyer afterwards. Having said all that, REALLY not a big fan of the 12 month trial. Seems like

[Longholder99]

This is still a very young company. With the SP where it is and with so much potential, im going to continue to build my position and at a certain point when the numbers are there I will sell about half. Going to hold longer term on the rest.

[FullCurl]

Thanks for clarifying on feasibility revenue. As for concerns over a 12 month time frame, I feel that with the multiple feasibilities they are conducting, at different stages of completion, sales and revenue are going to be consistent. This study will likely just ensure revenue in a year.  In the mean time, direct sales and feasibilities being converted to sales between now and then will